Avacta Acquires Coris Bioconcept in Deal Potentially Worth £10.4M
Avacta said the deal for Coris is part of an M&A-focused strategy for expanding its diagnostics portfolio and gaining routes into testing markets.
InDx 2.0 is being supported by the Bangalore Life Sciences Cluster, the Rockefeller Foundation, the Bill & Melinda Gates Foundation, and FIND.
By using a bright fluorescent particle, the researchers were able to achieve between 95 and 96 percent sensitivity for their SARS-CoV-2 tests.
Abingdon Health to Distribute Salignostics' Pregnancy Test in UK, Ireland
Salignostics is based in Jerusalem and offers a number of saliva-based, lateral flow immunoassays.
MIT Spinout C2Sense Raises $8M in Second Closing of Series B
The firm intends to use the money toward developing its Halo low-cost, compact lateral flow assay reader of colorimetric and fluorescent rapid tests.
Aug 18, 2022
CorDx Gets CE-IVD Marks for Monkeypox Assays
May 31, 2022
May 18, 2022
Mar 17, 2022
Jan 20, 2022